PARP1 and ovarian carcinoma: Inhibition of PARP1, an enzyme that can catalyze Poly(ADP-ribose) (PAR) formation, and plays a role in DNA damage repair [33], was recently shown to promote ferroptosis via repressing SLC7A11 and has a synergetic effect in BRCA-proficient ovarian cancer [34].